Biontech Se ADR (BNTX)
$86.81
0.64 (0.74%)
BNTX Stock Quote Delayed 30 Minutes
Is BioNTech a Buy Ahead of Earnings?
Many biotech companies are working on COVID-19 vaccines, but I believe BioNTech stands to be one of the biggest winners in the months ahead.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.58M
Day's Range
$85.63 - $87.59
52-Week Range
$85.21 - $125.83
Dividend & Yield
N/A (N/A)
BNTX Stock Predictions, Articles, and Biontech Se ADR News
What Will the Stock Market Do Today, Aug. 23? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on gig economy stocks like Uber after a judge ruled Proposition 22 was unconstitutional.
What Did the Stock Market Do Today, Aug. 16? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes are on the ARKK ETF and its top holdings, like Tesla stock, following a new short report.
Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks Today
Today, investors in vaccine stocks are seeing a lot of red, as investors seem to be taking some risk off the table ahead of Fed tapering.
Why This Fundamentally Superior Biotech Is Soaring
This biotech stock has had a good run-up as of late. But does that mean it should be the only one you invest in? Nope. And here's why.
What Did the Stock Market Do Today, Aug. 9? 3 Big Stories to Catch Up On.
So what did the stock market do today? Investors rallied behind cryptocurrency stocks after lawmakers reached a tax compromise.
Why These Biotech Stocks Are Soaring
There’s major potential for all of these biotech stocks, especially after full FDA approval, but this one stands to be one of the top winners.
What to Know About the Pfizer Booster Trial and New Vaccine Moves for PFE Stock
PFE stock is gaining these morning even as the FDA pushes back against Pfizer booster trial news and plans for a new shot.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on short squeeze stocks like ANY stock and the Bullish crypto exchange SPAC merger.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on the latest Covid-19 vaccine news, rising oil prices and the reopening story.
What Can BioNTech Do for an Encore?
If investors are expecting BNTX stock to continue generating double digit gains, they should be taking a careful look at its pipeline.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? Investors are carefully scrutinizing a $2 trillion infrastructure spending bill from President Biden.
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
The Question to Ask About COVID-19 Vaccine Stocks
The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started. Here's where to focus instead.
How to Invest in a Post-COVID World
Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively.
With Pfizer Partnership, BioNTech Stock Should Push Higher
In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible.
